Table 2.
Reference category for analysis | Analysed category | OR (95% confidence interval) for vascular pathology | P-value for vascular pathology | OR (95% confidence interval) for cerebrovascular disease | P-value for cerebrovascular disease |
---|---|---|---|---|---|
Alzheimer’s disease | FTLD-Tau | 0.37 (0.28–0.50) | <0.0001 | 0.38 (0.25–0.57) | <0.0001 |
Alzheimer’s disease | FTLD-TDP | 0.40 (0.28–0.58) | <0.0001 | 0.20 (0.09–0.42) | <0.0001 |
Alzheimer’s disease | Hippocampal sclerosis | 1.37 (0.64–2.98) | 0.41 | 1.10 (0.59–2.04) | 0.76 |
Alzheimer’s disease | α-Synucleinopathy | 0.38 (0.28–0.52) | <0.0001 | 0.47 (0.31–0.70) | 0.0002 |
Alzheimer’s disease | Prion disease | 0.13 (0.08–0.23) | <0.0001 | 0.24 (0.07–0.83) | 0.024 |
Alzheimer’s disease | Unremarkable Brain | 0.49 (0.39–0.61) | <0.0001 | – | – |
α-Synucleinopathy | FTLD-TDP | 1.16 (0.71–1.91) | 0.56 | 0.47 (0.19–1.17) | 0.11 |
α-Synucleinopathy | FTLD-Tau | 0.96 (0.63–1.45) | 0.85 | 0.75 (0.42–1.35) | 0.34 |
FTLD-TDP | FTLD-Tau | 0.84 (0.53–1.33) | 0.46 | 0.84 (0.53–1.33) | 0.46 |